Drug intelligence / Profile preview

OsteoVive Plus

Development stage
Unknown
Lead developer
Xtant Medical
Modality
Tissue Cells → Other Cell Types → Cell Therapies
Administration
Surgical Implantation
01

Overview

OsteoVive Plus is a moldable, viable cellular bone matrix allograft designed for use in a variety of bone grafting procedures. It is composed of donated human tissue, specifically mineralized and demineralized bone microparticulates combined with viable cells derived from the vertebral body region, which is rich in mesenchymal stem cells (MSCs). The product features Advanced Purloc Fiber Technology, providing a high concentration of elongated cortical fibers with consistent cross-sectional geometry to create a cohesive and moldable allograft for optimal surgical placement. The matrix offers osteoconductive scaffolding, osteoinductive potential due to inherent growth factors in the demineralized component, and osteogenic potential from its reliable cell population. It is processed aseptically using proprietary techniques that exceed FDA and AATB guidelines and uses a DMSO-free polyampholyte-based cryoprotectant to preserve cell viability without requiring decanting prior to use. Intended as a bone void filler for orthopedic applications such as spinal fusion or repair of bony defects[1][2][4].

Brand names
OsteoVive Plus
Other names
OsteoVive+

Beyond the preview

Go deeper on OsteoVive Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OsteoVive Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call